<p>The sub-chronic treatment was given concomitantly with L-DOPA for 4 days and animals were filmed on the 5<sup>th</sup> day (A). Total number of dyskinesias (B) and total distance travelled (C) over 6 h of film are presented and a significant reduction in LID counts is observed. Data are expressed as mean ± s.e.m. Unpaired Student <i>t</i> test (**, p<0.01).</p
<p>Evolution of <i>(</i><b><i>A</i></b><i>)</i> AIM scores/session, showing significant reduction af...
<p>A. UWA-101 (3, 6, 10 mg/kg), when co-administered with L-DOPA, significantly increased duration o...
<p><b>(A)</b> At 8 and 10 months following initiation of BSSG exposure, animals displayed a time-dep...
<p>The 5-day sub-chronic treatment with 5 mg/kg IRC was given concomitantly with L-DOPA and the tota...
<p>A single dose of 5 mg/kg of IRC was given 2 hours before administration of L-DOPA and the total n...
<p>Quantification of L-DOPA-induced dyskinesias at 2.5, 5 and 10 mg/kg IRC-082451 compared to vehicl...
<p>. The time course of changes in dyskinesia evaluated from the sum (A), locomotive (B) or the glob...
The development of dyskinesias following chronic L-DOPA replacement therapy remains a major problem ...
<div><p>The development of dyskinesias following chronic L-DOPA replacement therapy remains a major ...
International audienceThe development of dyskinesias following chronic L-DOPA replacement therapy re...
The development of dyskinesias following chronic L-DOPA replacement therapy remains a major problem ...
<p>(A) Evolution of daily motor scores during L-Dopa treatment. Timelines are aligned such that day ...
<p>Three different doses of amantadine were acutely injected together with L-DOPA and a significant ...
<p>A. Dyskinesia time course. At no time during the 6 h observation period did UWA-101 (1, 3, 6, 10 ...
<p>Animals were subjected to on-line microdialysis measurements either under baseline conditions, or...
<p>Evolution of <i>(</i><b><i>A</i></b><i>)</i> AIM scores/session, showing significant reduction af...
<p>A. UWA-101 (3, 6, 10 mg/kg), when co-administered with L-DOPA, significantly increased duration o...
<p><b>(A)</b> At 8 and 10 months following initiation of BSSG exposure, animals displayed a time-dep...
<p>The 5-day sub-chronic treatment with 5 mg/kg IRC was given concomitantly with L-DOPA and the tota...
<p>A single dose of 5 mg/kg of IRC was given 2 hours before administration of L-DOPA and the total n...
<p>Quantification of L-DOPA-induced dyskinesias at 2.5, 5 and 10 mg/kg IRC-082451 compared to vehicl...
<p>. The time course of changes in dyskinesia evaluated from the sum (A), locomotive (B) or the glob...
The development of dyskinesias following chronic L-DOPA replacement therapy remains a major problem ...
<div><p>The development of dyskinesias following chronic L-DOPA replacement therapy remains a major ...
International audienceThe development of dyskinesias following chronic L-DOPA replacement therapy re...
The development of dyskinesias following chronic L-DOPA replacement therapy remains a major problem ...
<p>(A) Evolution of daily motor scores during L-Dopa treatment. Timelines are aligned such that day ...
<p>Three different doses of amantadine were acutely injected together with L-DOPA and a significant ...
<p>A. Dyskinesia time course. At no time during the 6 h observation period did UWA-101 (1, 3, 6, 10 ...
<p>Animals were subjected to on-line microdialysis measurements either under baseline conditions, or...
<p>Evolution of <i>(</i><b><i>A</i></b><i>)</i> AIM scores/session, showing significant reduction af...
<p>A. UWA-101 (3, 6, 10 mg/kg), when co-administered with L-DOPA, significantly increased duration o...
<p><b>(A)</b> At 8 and 10 months following initiation of BSSG exposure, animals displayed a time-dep...